missed period on semaglutide A FAERS pharmacovigilance analysis published in Obstetrics & Gynecology found generated signals for heavy menstrual bleeding, menstrual clots, intermenstrual bleeding, oligomenorrhea, and anovulatory cycles in female patients aged 12 to 55 Starting GLP-1 treatment and noticing

Their regulatory status ranges from legally compoundable with a prescription (sermorelin) to explicitly restricted injectable formulations (GHK-Cu under the FDA Category 2 list) to regulatory limbo (CJC-1295 and ipamorelin following the September 2024 removal from the 503A compounding bulks list)

Neuropsychiatr Dis Treat 10:18871896

Accelerates the Healing Process GHKCu supports all four phases of wound healinghemostasis, inflammation, proliferation, and remodelingby promoting angiogenesis and enhancing the expression of TGF and VEGF , which are critical for new tissue formation and vascularization

Cases were generally mild to moderate, most resolved while treatment continued, and most participants stayed on the drug but it is a real, dose-related effect and its mechanism is not yet fully explained